Navigation Links
New Jersey Health Foundation Awards First Two Innovation Stage Funding Grants
Date:1/23/2013

NEW BRUNSWICK, N.J., Jan. 23, 2013 /PRNewswire-USNewswire/ -- Dr. Tomer Davidov and Dr. William C. Gause are the first two recipients of grants from New Jersey Health Foundation's Innovation Stage Funding Program to advance their medical research that could eventually be commercialized for consumer benefit.

Dr. Davidov, an assistant professor of surgery at Robert Wood Johnson Medical School in New Brunswick, is developing a novel puncture resistant surgical glove that will offer healthcare professionals the highest level of needle stick protection without compromising tactile sensation and manual dexterity.

"Needle-stick injury is a common problem among healthcare professions, with 4 million estimated injuries annually in the United States," Dr. Davidov said.  "One study in the New England Journal of Medicine found that a staggering 99% of surgeons reported a needle stick injury during their training alone, 53% of which were with high risk patients.  It is no wonder that 96% of surveyed surgeons are concerned about contracting HIV or Hepatitis C as a result of needle stick injuries."

According to Dr. Davidov, current tear resistant gloves use thicker standard material, but do not provide true needle stick puncture protection.  He will use the grant from the Innovation Stage Funding Program to develop the prototype for a surgical glove that uses a novel manufacturing process and a newly developed puncture resistant, flexible, paper-thin material.

Dr. Gause, the senior associate dean for research at New Jersey Medical School in Newark, has developed a new approach to enhance the treatment of wound healing using compositions derived from metazoan parasites at the site of an injury.  His grant will be used to further develop a potential commercial product.

"Chronic wounds represent a significant burden to patients, healthcare professionals and the U.S. health care system, affecting 5.7 million patients and costing an estimated 20 billion dollars annually," said Dr. Gause.  "Our research to date shows that the characteristic type of immune response triggered by macroparasites has active components that can enhance tissue repair and wound healing."

Through the Innovation Stage Funding Program, New Jersey Health Foundation has allocated $500,000 to provide grants from $10,000 up to $50,000 each to researchers with promising ideas to advance an intellectual property toward commercialization through a start-up.  At the current time, researchers with these objectives affiliated with the University of Medicine and Dentistry of New Jersey (UMDNJ) are able to apply for funding.

For more information and to check eligibility, visit the What's New section at www.foundationofumdnj.org.  

About New Jersey Health Foundation

New Jersey Health Foundation (www.njhf.org,) established in 2002 as a not-for-profit public charity, is the parent company to the Foundation of UMDNJ (www.foundationofumdnj.org) and The Foundation for Healthcare Advancement (www.foundationforhealthcareadvancement.org), which solicit private sector support for the University of Medicine and Dentistry of New Jersey and to Foundation Venture Capital Group, LLC,  (www.foundationventure.com) which makes private equity investments in start-up technology companies founded by researchers affiliated with the University.


'/>"/>
SOURCE New Jersey Health Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
2. Eisai USA Foundation to Donate $100,000 to the Hurricane Sandy New Jersey Relief Fund, $50,000 to the American Red Cross
3. New Jersey Lawsuit About the Dietary Supplement Relacore Certified to Proceed As a Class Action
4. New Jersey Health Foundation Commits $2 Million to Fund Grants
5. In Observance of Veterans Day Reproductive Medicine Associates of New Jersey Extends "Helping Heroes Build Families" Program
6. New Jersey Health Foundation Initiates Program To Spur Innovative Research
7. Prostate Cancer Center of New Jersey the Latest Center to Achieve High Honor of ACR-ASTRO Accreditation
8. Clinilabs Opens Phase I Unit In Eatontown, New Jersey
9. New Jersey Ophthamologist Now Offers Pelleve Wrinkle Reduction Treatment
10. Dr. Phillip Chan Named Finalist for Ernst & Young Entrepreneur of the Year® 2012 Award in New Jersey
11. Global Pharmaceutical Leaders All Converging in Parsippany, New Jersey on September 11-12, 2012 for Breakthrough Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2017)... ORLANDO, Fla. , July 17, 2017  MedX ... - branded medical testing, strengthening and rehabilitation equipment, today ... Back Machine Program. MedX is considered the gold standard ... world leader in specialized medical strengthening equipment. ... into a lease with the physician or practice who ...
(Date:7/13/2017)... 2017  Centurion Medical Products, a leader in medical product innovation ... impaction removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part of ... patient pain while preventing unneeded emergency department admission due to severe ...
(Date:7/12/2017)... , July 12, 2017  Eli Lilly and Company (NYSE: ... with generic companies to resolve pending patent litigation in the ... Virginia regarding the Cialis ® (tadalafil) unit ... April 26, 2020. As part of the agreement, Cialis exclusivity ... 27, 2018. "The unit dose patent for Cialis ...
Breaking Medicine Technology:
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the use of violence and aggression to solve problems and pleads with world leaders to ... and armed forces do not bring peace. He says there is a peaceful and positive ...
(Date:7/21/2017)... NEW ORLEANS, La. (PRWEB) , ... July 21, ... ... tool to allow 4th-year medical students improve their chances of acceptance to a ... particularly for those who have earned degrees outside the U.S. , According to ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... EyeMist®, the signature product of her research center at Bio-Logic Aqua Research® Water ... population and the greatest number of sufferers of blindness. “We think that Nature’s ...
(Date:7/21/2017)... ... 21, 2017 , ... In the first prospective ACL reconstruction ... Outcome Network (MOON) demonstrated that patients could perform sports-related functions and maintain a ... over time. The study, presented today at the American Orthopaedic Society for ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... may give insight into why concussion rates are on the rise, say researchers ... Annual Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the ...
Breaking Medicine News(10 mins):